Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention
JACC · 2026-04 · 87 (16) · 2117-2130
DOI: 10.1016/j.jacc.2025.12.024 ↗Kurz gefasst
Äquivalenzstudie in der Zeitschrift JACC, 2026-04. Verfasst von Runlin Gao und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical C…. Hauptthemen laut MEDLINE: Absorbable Implants, Coronary Artery Disease, Drug-Eluting Stents, Everolimus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Cardiology, Fuwai Yunnan Hospita…
- Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiova…
- Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Catheterization Laboratories, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
- Department of Cardiology, General Hospital of Ningxia Medical University, Yinchuan, China.
Zitieren
APA
Gao, R., Song, L., Fu, G., Guan, C., Li, Y., Jia, S., He, Y., Chen, J., Qi, F., Yu, M., Yang, B., Zhang, Y., Zhang, Z., He, S., Chen, Y., Ma, Y., Zhou, Y., Wang, L., Zhao, G., …, & IRONMAN II Investigators (2026). Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention. JACC, 87(16), 2117-2130. https://doi.org/10.1016/j.jacc.2025.12.024
Vancouver
Gao R, Song L, Fu G, Guan C, Li Y, Jia S, et al. Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention. JACC. 2026;87(16):2117-2130. doi:10.1016/j.jacc.2025.12.024
BibTeX
@article{Gao2026,
author = {Gao, Runlin and Song, Lei and Fu, Guosheng and Guan, Changdong and Li, Yang and Jia, Shaobin and He, Yong and Chen, Jiyan and Qi, Feng and Yu, Mengyue and Yang, Bo and Zhang, Yaojun and Zhang, Zheng and He, Shenghu and Chen, Yundai and Ma, Yitong and Zhou, Yujie and Wang, Le and Zhao, Guowei and Qian, Juying and Guo, Ning and Sun, Zhongwei and Huang, Yunfei and Li, Wei and Wang, Yang and Ge, Junbo and Han, Yaling and Stone, Gregg W and IRONMAN II Investigators, IRONMAN II Investigators},
title = {Sirolimus-Eluting Iron Bioresorbable Scaffolds vs Everolimus-Eluting Stents for Percutaneous Coronary Intervention},
journal = {JACC},
year = {2026},
volume = {87},
number = {16},
pages = {2117--2130},
doi = {10.1016/j.jacc.2025.12.024}
}
EUVIMED